General
Preferred name
CIMETIDINE
Synonyms
SKF-92334 ()
Ulcimet ()
Cimetidinum ()
Tagamet ()
Ulcedin ()
Ulcomedina ()
Cimal ()
Peptimax 800 ()
Tagamet 100 ()
Dyspamet ()
Zita ()
NSC-335308 ()
Cimetidina ()
Brumetidina ()
Tagamet HB ()
Kentamet ()
Acinil ()
Brumetadina ()
Acitak 400 ()
Acitak 800 ()
Acitak 200 ()
Peptimax 400 ()
Galenamet ()
Aciloc ()
Acid-eze ()
Tagadine ()
Tagamet HB 200 ()
Gastromet ()
Peptimax 200 ()
Ultec ()
Valmagen ()
Stomedine ()
Cimetidine hcl ()
CIMETIDINE HYDROCHLORIDE ()
Cimetidine-d3 ()
P&D ID
PD001634
CAS
51481-61-9
71989-90-7
2984-61-4
1185237-29-9
Tags
available
biased GPCR ligand
drug
Approved by
FDA
First approval
1977
Drug indication
Gastroesophageal reflux disease
Acid-reflux disorder
Drug Status
approved
investigational
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cimetidine is a histamine H2 receptor antagonist. (GtoPdb)
PRICE 29
DESCRIPTION Cimetidine (SKF-92334) is an orally active and inverse histamine H2 receptor antagonist with a Ki of 0.6 ¦ÌM. Cimetidine is a gastric acid reducer, and can be used for duodenal and gastric ulcers research. Cimetidine has anti-cancer and anti-inflammatory activity[1][2][5].
DESCRIPTION inhibitor of histidine receptor H2 (Informer Set)
DESCRIPTION Cimetidine is a histamine-2 (H2) receptor antagonist. It is used to manage GERD, peptic ulcer disease, and indigestion. (Enamine Bioactive Compounds)
DESCRIPTION H2 antagonist, I1 agonist (Tocriscreen Plus)
DESCRIPTION H2 Histamine receptor antagonist; anti-ulcer agent (LOPAC library)
DESCRIPTION H2 antagonist, I1 agonist (Tocriscreen Total)
DESCRIPTION Potent and selective group I mGlu antagonist (Tocris Bioactive Compound Library)
DESCRIPTION Cimetidine (SKF-92334) is a histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
1
Compound Sets
38
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
Informer Set
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
ZINC Tool Compounds
External IDs
213
Properties
(calculated by RDKit )
Molecular Weight
252.12
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
3
Rotatable Bonds
5
Ring Count
1
Aromatic Ring Count
1
cLogP
0.6
TPSA
88.89
Fraction CSP3
0.5
Chiral centers
0.0
Largest ring
5.0
QED
0.31
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
HRH2
HRH2, SLC29A4, SLC47A1, SLC47A2
Histamine Receptor
Bacterial
H2 receptor
Compound status
FDA
Target Type
7-TM Receptors
Selectivity
H2
Pathway
GPCR/G protein
Immunology/Inflammation
Neuroscience
Anti-infection
Neuronal Signaling
Primary Target
Histamine H2 Receptors
MOA
Antagonist
Histamine Receptor antagonist
Indication
duodenal ulcer disease, peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), aggressive systemic mastocytosis (ASM), Zollinger-Ellison syndrome, endocrine adenoma
Disease Area
gastroenterology, hematologic malignancy, endocrinology
Therapeutic Class
Antiulcer Agents
Source data